Drug giant Sanofi becomes latest to cap US insulin prices The move follows public outcry over the drug's costs, but it also may help the firms' bottom line.
|
Toplista
Hirdetés |
Drug giant Sanofi becomes latest to cap US insulin prices The move follows public outcry over the drug's costs, but it also may help the firms' bottom line.
|
Toplista
Hirdetés |